Ausgabe 7/2018
Inhalt (11 Artikel)
Possibly no baseline severity effect for antidepressants versus placebo but for antipsychotics. Why?
Stefan Leucht, S. Z. Levine, M. Samara, A. Cipriani, J. M. Davis, T. A. Furukawa
Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis
Marc Krause, Yikang Zhu, Maximilian Huhn, Johannes Schneider-Thoma, Irene Bighelli, Adriani Nikolakopoulou, Stefan Leucht
Neural substrate of unrelenting negative symptoms in schizophrenia: a longitudinal resting-state fMRI study
Mingli Li, Wei Deng, Tushar Das, Yinfei Li, Liansheng Zhao, Xiaohong Ma, Yingcheng Wang, Hua Yu, Xiaojing Li, Ya-jing Meng, Qiang Wang, Lena Palaniyappan, Tao Li
Auditory feature perception and auditory hallucinatory experiences in schizophrenia spectrum disorder
Ashley M. Schnakenberg Martin, Lisa Bartolomeo, Josselyn Howell, William P. Hetrick, Amanda R. Bolbecker, Alan Breier, Gary Kidd, Brian F. O’Donnell
Treatment of auditory hallucinations with bilateral theta burst stimulation (cTBS): protocol of a randomized, double-blind, placebo-controlled, multicenter trial
Christian Plewnia, Bettina Brendel, Tobias Schwippel, Peter Martus, Joachim Cordes, Alkomiet Hasan, Andreas J. Fallgatter
Is electroconvulsive therapy an evidence-based treatment for catatonia? A systematic review and meta-analysis
Arnaud Leroy, Florian Naudet, Guillaume Vaiva, Andrew Francis, Pierre Thomas, Ali Amad
Olfactory deficits in individuals at risk for psychosis and patients with schizophrenia: relationship with socio-cognitive functions and symptom severity
Tsutomu Takahashi, Mihoko Nakamura, Daiki Sasabayashi, Yuko Komori, Yuko Higuchi, Yumiko Nishikawa, Shimako Nishiyama, Hiroko Itoh, Yuri Masaoka, Michio Suzuki
Individual trajectories of cognitive performance in first episode psychosis: a 2-year follow-up study
A. M. Sánchez-Torres, L. Moreno-Izco, R. Lorente-Omeñaca, B. Cabrera, A. Lobo, A. M. González-Pinto, J. Merchán-Naranjo, I. Corripio, E. Vieta, E. de la Serna, A. Butjosa, F. Contreras, S. Sarró, G. Mezquida, M. Ribeiro, M. Bernardo, M. J. Cuesta, Miquel Bioque, Silvia Amoretti, Elisa Rodríguez Toscano, Ángel del Rey Mejías, Anna Alonso, Mireia Rabella, Itxaso González-Ortega, Mónica Martínez-Cengotitabengoa, Julio Arbej, Pedro Ruiz, Julio Sanjuan, Eduardo J. Aguilar, Anna Mané, Iris Cáceres, Carla Torrent, Brisa Solé, Immaculada Baeza, Josefina Castro-Fornieles, Àuria Albacete, Jose Manuel Menchón, Leticia García-Álvarez, Susana Al-Halabí Díaz, Miguel Gutiérrrez, Rafael Segarra, Isabel Morales-Muñoz, Roberto Rodriguez-Jimenez, Elena Rubio-Abadal, Judith Usall, Ramón Landín-Romero, Edith Pomarol-Clotet, Ángela Ibáñez, Jose M. López-Ilundain, Vicente Balanzá-Martínez
Self-disorders in schizophrenia-spectrum disorders: a 5-year follow-up study
Julie Nordgaard, Lars Siersbæk Nilsson, Ditte Sæbye, Josef Parnas
Increased pericardial adipose tissue and cardiometabolic risk in patients with schizophrenia versus healthy controls
J. Ruppert, D. Hartung, M. Westhoff-Bleck, J. Herrmann, B. Stubbs, J. Cordes, T. H. C. Krüger, R. Lichtinghagen, K. G. Kahl
Cannabinoids and glial cells: possible mechanism to understand schizophrenia
Valéria de Almeida, Daniel Martins-de-Souza